Source comparison
Comparative Mechanism: Melanotan-2 vs PDE5 Inhibitors
The functional difference between melanotan-2 and sildenafil (Viagra), tadalafil (Cialis), or vardenafil (Levitra) comes down to where each compound acts in the erectile cascade. PDE5 inhibitors work at the tissue level. They block the enzyme phosphodiesterase
This comparison does not assign a generated winner or score.
- The functional difference between melanotan-2 and sildenafil (Viagra), tadalafil (Cialis), or vardenafil (Levitra) comes down to where each compound acts in the erectile cascade. PDE5 inhibitors work at the tissue level. They block the enzyme phosphodiesterase type 5, which degrades cyclic GMP (cGMP), the molecule responsible for smooth muscle relaxation in the corpus cavernosum. More cGMP means better vasodilation and improved erectile rigidity. But only if the initial NO signal is present.
- Melanotan-2 doesn't touch cGMP or PDE5. It operates entirely upstream, at the level of the central nervous system. By binding MC4R in the hypothalamus, it initiates the NO signal that PDE5 inhibitors amplify. This means it can produce erections in men whose baseline NO production is impaired. Whether due to neuropathy, psychological inhibition, or autonomic dysfunction. The 2025 Journal of Sexual Medicine trial demonstrated exactly this: 64% response rate in treatment-resistant ED, defined as prior PDE5 inhibitor failure.
- The tradeoff is specificity. PDE5 inhibitors require arousal, which gives the user control over timing. Melanotan-2 doesn't. Once MC4R is activated, the downstream cascade proceeds regardless of context. Spontaneous erections within 4–6 hours of administration are common, which is why research protocols typically dose in the evening before sleep. Duration differs as well: PDE5 inhibitor effects last 4–36 hours depending on the compound, whereas melanotan-2's central receptor activation can persist for 72 hours due to its half-life of approximately 33 minutes but prolonged receptor occupancy.